
Annalaura Mastrangelo
pharmacologistFemale0.0Global Dominance: 0.00%
Annalaura Mastrangelo is an Italian pharmacologist who co-authored a significant study on atherosclerosis. Her collaboration includes developing a drug that effectively blocks the receptor for propionato de imidazol, potentially preventing the progression of atherosclerosis in patients. This groundbreaking work showcases her commitment to advancing cardiovascular health research.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Annalaura Mastrangelo is a co-author of the experimental treatment patented alongside David Sancho.
Revolución en la medicina: una molécula producida por bacterias del intestino causa la aterosclerosis, culpable de millones de muertes | Salud y bienestarEl País·
Spain· 2025-07-16









